TLPH - TALPHERA, INC.

0.502
-0.009   -1.773%

Share volume: 26,946
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$0.51
-0.01
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 0%
Dept financing 40%
Liquidity 50%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-11.91%
1 Month
-5.28%
3 Months
-13.58%
6 Months
-36.49%
1 Year
-57.09%
2 Year
-22.07%
Key data
Stock price
$0.50
P/E Ratio 
0.00
DAY RANGE
$0.49 - $0.53
EPS 
-$0.31
52 WEEK RANGE
$0.45 - $1.27
52 WEEK CHANGE
-$57.82
MARKET CAP 
14.556 M
YIELD 
N/A
SHARES OUTSTANDING 
16.993 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.16
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$114,201
AVERAGE 30 VOLUME 
$50,393
Company detail
CEO: Vincent J. Angotti
Region: US
Website: talphera.com
Employees: 19
IPO year: 2011
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.

Recent news
loading